Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more
Job title: MD
Dr Juan F. Iglesias is an interventional cardiologist at Geneva University Hospitals and Privat Docent at the University of Geneva, Switzerland. He obtained his medical degree at Lausanne University Hospitals in Switzerland and completed his general and interventional cardiology training at the same institution, at the London Chest Hospital (Barts Health NHS Trust, London, United Kingdom) and at… View more
Antoni Bayés-Genís
Research Area(s) / Expertise: Job title: Head of the Cardiology Department
Dr Antoni Bayés-Genís is Professor of Cardiology at the Universitat Autònoma de Barcelona, Spain and Head of the Cardiology Department at the University Hospital Germans Trias i Pujol, Barcelona. Dr Bayés-Genís is also an expert on biomarker, including natriuretic peptides ST2 and neprilysin, having lectured on the subject at numerous international meetings and generated research data that… View more
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
Author(s): Tamara García Camarero , José M de la Torre Hernández Added: 3 years ago
The use of dual antiplatelet therapy (DAPT) after stent implantation in a percutaneous coronary intervention (PCI) is the standard treatment. The first randomised controlled trial (RCT) to establish the superiority of DAPT versus oral anticoagulant treatment among patients undergoing PCI was the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial, published in 1996.1 Since then, more… View more

Anticoagulation
Dual-pathway Inhibition versus Aspirin Monotherapy
Author(s): Dirk Sibbing , Michael J Blaha , Rajinder Chawla , et al Added: 2 weeks ago

Anticoagulation

Prevention & Chronic Conditions
PCI Outcomes in Women
Author(s): Antonia Sambola , Bruno García Del Blanco , Vijay Kunadian , et al Added: 1 year ago

Vascular Disease and Surgery

MI/ACS
Kian Keong Poh
Job title: Senior Consultant, Director of Postgraduate Education and Clinical Director of Research
Professor Poh Kian Keong is presently a Senior Consultant, Director of Postgraduate Education and Clinical Director of Research at the Department of Cardiology, NUHCS. His training in cardiology took place in Cardiac Department at NUH. Subsequently, he worked at St Elizabeth Medical Centre, Tufts University School of Medicine, Boston on novel therapies for cardiovascular conditions, including… View more
Bernard J Gersh
Research Area(s) / Expertise: Job title: Professor of Medicine
Professor of Medicine at Mayo Clinic College of Medicine, Consultant in Cardiovascular Diseases and Internal Medicine. His past positions include The W. Proctor Harvey Teaching Professor of Cardiology and Chief of the Division of Cardiology at Georgetown University Medical Center. Dr. Gersh received his MB, ChB, from the University of Cape Town in South Africa. He received his Doctor of… View more
Direct-acting Anticoagulants in Chronic Coronary Syndromes
Author(s): Emmanuel Sorbets , Philippe Gabriel Steg Added: 3 years ago
Despite improvements in the management of coronary artery disease over the last decades, ischaemic heart disease remains the leading cause of mortality worldwide and the leading cause of premature death.1,2 Patients with chronic coronary syndromes (CCS) encompass a heterogeneous population, including those with demonstrable coronary artery disease by anatomical testing or evidence of ischaemia,… View more

Anticoagulation

Electrophysiology & Arrhythmia
Air Pollution, Inflammatory Biomarkers and Infarct Size In STEMI Patients
Author(s): Laura Díaz-Chirón , Luis Negral , Laura Megido , et al Added: 2 years ago

Vascular Disease and Surgery